Efficacy and safety of first-line PD-1/PD-L1 inhibitor combinations for extensive-stage small-cell lung cancer: a Bayesian network meta-analysis

OBJECTIVES: Several randomized controlled trials (RCTs) indicated that first-line programmed cell death protein-1/death-ligand 1 inhibitors plus chemotherapy (PD-1/PD-L1 + chemo) led to survival benefits in extensive-stage small-cell lung cancer (ES-SCLC) compared with platinum-based chemotherapy. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Huijuan, Han, Hedong, Li, Chuling, Wu, Ranpu, Wang, Zhaofeng, Wang, Yimin, Zhan, Ping, Lv, Tangfeng, Zhang, Fang, Song, Yong, Liu, Hongbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599110/
https://www.ncbi.nlm.nih.gov/pubmed/37885460
http://dx.doi.org/10.1177/17588359231189430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599110/
https://www.ncbi.nlm.nih.gov/pubmed/37885460
http://dx.doi.org/10.1177/17588359231189430

Ejemplares similares